Research field (3):
Molecular biology
, Systems genomics
, Medical biochemistry
Research theme for competitive and other funds (3):
2022 - 2025 エピジェネティックなDNA損傷履歴蓄積と老化
2019 - 2022 Decline in the histone level and organismal aging
2012 - 2013 細胞の運命転換における選択的スプライシング制御機構の解析
Papers (17):
Jumpei Taguchi, Yosuke Yamada, Sho Ohta, Fumie Nakasuka, Takuya Yamamoto, Manabu Ozawa, Yasuhiro Yamada. A versatile in vivo platform for reversible control of transgene expression in adult tissues. Stem cell reports. 2024
Sho Ohta, Yasuhiro Yamada. Exploring the potential of in vivo reprogramming for studying embryonic development, tissue regeneration, and organismal aging. Current Opinion in Genetics & Development. 2023. 81. 102067-102067
Yui Shimada-Takayama, Takayuki Yasuda, Tomoyo Ukai, Jumpei Taguchi, Manabu Ozawa, Nao Sankoda, Sho Ohta, Yasuhiro Yamada. Generation of mice for evaluating endogenous p16Ink4a protein expression. Biochemical and biophysical research communications. 2022. 599. 43-50
Kenji Ito, Kohei Nagata, Sho Ohta, Yutaka Matsuda, Tomoyo Ukai, Ichiro Yasuda, Akira Ota, Ryota Kobayashi, Mio Kabata, Nao Sankoda, et al. The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets. Cell Reports. 2022. 39. 4. 110721-110721